The AstraZeneca PLC (AZN) revenue growth is 13.8%, which is lower than the industry median of 5.6% and the 5-year historical average of 17.0%.
The AstraZeneca PLC (AZN) operating income growth is 39.1%, compared to the industry median of 17.2% and the 5-year historical average of 604.7%.
The AstraZeneca PLC (AZN) EPS growth is (2.1%), compared to the industry median of (21.3%) and the 5-year historical average of 70.6%.
The AstraZeneca PLC (AZN) Free Cash Flow growth is (3.2%), compared to the industry median of 18.1% and the 5-year historical average of 67.3%.